Department of Psychiatry, Queen Mary Hospital, The University of Hong Kong, Pokfulam, Hong Kong.
State Key Laboratory of Brain and Cognitive Sciences, Hong Kong Jockey Club Building for Interdisciplinary Research, The University of Hong Kong, Pokfulam, Hong Kong.
Aust N Z J Psychiatry. 2023 Jun;57(6):854-864. doi: 10.1177/00048674221121575. Epub 2022 Sep 4.
Schizophrenia-spectrum disorder (SSD) is associated with increased premature death, with emerging data suggesting early illness course as a high-risk period for excess mortality. This study aimed to examine mortality rate in patients with incident SSD and differential mortality risk between inpatient-diagnosed and outpatient-diagnosed subsamples within 5 years of first diagnosis.
This population-based cohort study identified 8826 patients aged 18-39 years receiving first-recorded SSD diagnosis upon service entry, comprising 3877 inpatient-diagnosed and 4949 outpatient-diagnosed patients, between 2006 and 2012 in Hong Kong using a territory-wide medical record database of public health care services. All-cause, natural-cause, and unnatural-cause mortality risks within 5 years after first diagnosis were quantified by standardized mortality ratios (SMRs) relative to the general population. We also directly compared mortality rates between inpatient and outpatient subsamples over 5-year follow-up.
SSD patients exhibited markedly elevated all-cause (SMR: 12.28, 95% confidence interval [CI]: [10.83, 13.88]), natural-cause (SMR: 3.76, 95% CI: [2.77, 4.98]) and unnatural-cause (SMR: 20.64, 95% CI: [17.49, 24.20]) mortality during first 5 years of diagnosis. Increased mortality rate was most pronounced in the first year of treatment, especially for unnatural deaths (SMR 32.2, 95% CI: [24.08, 42.22]). Discharged inpatient-diagnosed patients displayed significantly higher all-cause and unnatural-cause mortality rates than outpatient-diagnosed counterparts within first 3 years of treatment, and differential mortality risks on all-cause (adjusted hazard ratio [aHR]: 7.05, 95% CI: [2.02, 24.64]) and unnatural-cause (aHR: 5.15, 95% CI: [1.38, 19.19]) deaths were the highest in the first month of follow-up.
Substantial increase in early mortality risk among people with incident SSD, particularly in the first year of diagnosis and the time shortly after discharge, underscores an urgent need of targeted early intervention for effective suicide prevention and physical health improvement to minimize mortality gap.
精神分裂症谱系障碍(SSD)与过早死亡风险增加相关,越来越多的数据表明疾病早期是导致死亡率过高的高危时期。本研究旨在探讨 SSD 发病后患者的死亡率,并比较首次诊断后 5 年内住院诊断和门诊诊断亚组之间的差异死亡率。
本基于人群的队列研究纳入了 2006 年至 2012 年在香港公共医疗服务的全港医疗记录数据库中首次记录 SSD 诊断的 8826 名 18-39 岁患者,包括 3877 名住院诊断和 4949 名门诊诊断患者。采用标准化死亡率比(SMR)来衡量首次诊断后 5 年内的全因、自然原因和非自然原因死亡率,并与一般人群进行比较。我们还在 5 年随访期间直接比较了住院和门诊亚组之间的死亡率。
SSD 患者在首次诊断后的前 5 年内表现出明显升高的全因(SMR:12.28,95%置信区间[CI]:[10.83,13.88])、自然原因(SMR:3.76,95%CI:[2.77,4.98])和非自然原因(SMR:20.64,95%CI:[17.49,24.20])死亡率。在治疗的第一年,死亡率增加最为显著,特别是非自然死亡(SMR 32.2,95%CI:[24.08,42.22])。在治疗的前 3 年内,出院的住院诊断患者的全因和非自然原因死亡率明显高于门诊诊断患者,并且在全因(调整后的危险比[aHR]:7.05,95%CI:[2.02,24.64])和非自然原因(aHR:5.15,95%CI:[1.38,19.19])死亡方面的差异死亡率在随访的第一个月最高。
精神分裂症谱系障碍患者的早期死亡率风险显著增加,特别是在诊断后的第一年和出院后不久,这迫切需要针对早期干预进行有针对性的干预,以有效预防自杀和改善身体健康,从而缩小死亡率差距。